Literature DB >> 31109898

Mechanisms Linking White Matter Lesions, Tract Integrity, and Depression in Alzheimer Disease.

Chathuri Yatawara1, Daryl Lee1, Kok Pin Ng1, Russell Chander1, Debby Ng1, Fang Ji2, Hee Youn Shim2, Saima Hilal3, Narayanaswamy Venketasubramanian4, Christopher Chen3, Juan Zhou2, Nagaendran Kandiah5.   

Abstract

OBJECTIVE: Late-life depression involves the disconnection of white matter tracts that regulate mood. A pathogenic link between poor tract integrity and depressive symptoms is believed to be white matter lesions (WML), however the mechanisms linking tract integrity, WML, and depression remains unexplored. The authors sought to identify whether the association between reduced tract integrity and depressive symptoms is mediated by WML in patients with Alzheimer disease (AD), and whether individual characteristics moderate this effect.
METHODS: This was a cross-sectional study in a tertiary memory clinic. A total of 91 patients with mild AD and 79 healthy elderly, comparable in depressive symptoms, white matter hyperintensities (WMH) volume, cardiovascular risk, age, and sex were chosen. Tract integrity was assessed using diffusion tensor imaging, WML were indexed as WMH, measured using fluid-attenuation inversion recovery imaging, and depressive symptoms were measured with the informant-based Geriatric Depression Scale.
RESULTS: In patients with mild AD, reduced tract integrity in right hemispheric cortical-subcortical tracts and the genu of the corpus callosum was moderately associated with depressive symptoms. This association was fully mediated by WML. Moderation analysis indicated that old age strengthened the association between all tracts and depressive symptoms, as mediated by WML. In cognitively healthy elderly, neither tracts nor WML were related to depressive symptoms.
CONCLUSION: Reduced tract integrity may be important but not sufficient for the manifestation of depressive symptoms in mild AD. Instead, WML may drive the pathogenic link between reduced tract integrity and depressive symptoms.
Copyright © 2019 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Cerebrovascular disease; dementia; depression; structural imaging; white matter tracts

Year:  2019        PMID: 31109898     DOI: 10.1016/j.jagp.2019.04.004

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  4 in total

1.  Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer's Disease.

Authors:  Anna Carotenuto; Angiola Maria Fasanaro; Valentino Manzo; Francesco Amenta; Enea Traini
Journal:  J Alzheimers Dis Rep       Date:  2022-05-23

2.  The Newly Normed SKT Reveals Differences in Neuropsychological Profiles of Patients with MCI, Mild Dementia and Depression.

Authors:  Hartmut Lehfeld; Mark Stemmler
Journal:  Diagnostics (Basel)       Date:  2019-10-25

3.  Brain Atrophy and White Matter Damage Linked to Peripheral Bioenergetic Deficits in the Neurodegenerative Disease FXTAS.

Authors:  Junyi Wang; Eleonora Napoli; Kyoungmi Kim; Yingratana A McLennan; Randi J Hagerman; Cecilia Giulivi
Journal:  Int J Mol Sci       Date:  2021-08-25       Impact factor: 5.923

Review 4.  Pathogeneses and Imaging Features of Cerebral White Matter Lesions of Vascular Origins.

Authors:  Xiaoqin Wu; Jingyuan Ya; Da Zhou; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.